Last reviewed · How we verify

NCT05156931: CASEME

Exploration of Patient Self-medication Practices During and After Cancer in France

Completed Last updated 4 May 2022
What this trial tests

trial in Cancer in 681 participants. Completed in 30 April 2022.

Timeline
14 December 2021
Primary endpoint
30 April 2022
30 April 2022

Quick facts

Lead sponsorUniversity Hospital, Clermont-Ferrand
StatusCompleted
Study typeOBSERVATIONAL
Enrollment681
Start date14 December 2021
Primary completion30 April 2022
Estimated completion30 April 2022
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Clermont-Ferrand

Who can join

18 and older, any sex, with Cancer or Self-medication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the patient self-medication practices during and after cancer in France, using an online questionnaire

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study.
    Maraud J, Bedhomme S, Pereira B, Trévis S, et al · · 2023 · cited 2× · PMID 37370800 · DOI 10.3390/cancers15123190

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other University Hospital, Clermont-Ferrand trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05156931.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing